Palisade Bio Inc. (NASDAQ: PALI) Stock Information | RedChip

Palisade Bio Inc. (NASDAQ: PALI) Listen to this Section


$3.94
+0.2250 ( +6.07% ) 19.2K

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Market Data


Open


$3.94

Previous close


$3.71

Volume


19.2K

Market cap


$3.69M

Day range


$3.53 - $3.95

52 week range


$3.30 - $28.95

Insider Ownership Transactions

Total Amount Purchased: 720.00 | $ 2,833.20

Date Type Amount Purchased Purchaser
2023-11-24 Sale -5820.00 Trenschel Robert J.
2023-11-24 Sale -28000.00 Jones Mitchell Lawrence
2023-11-24 Sale -5820.00 Diaz Stephanie
2023-11-08 Sale -3475.00 Finley John David
2023-11-08 Sale -4556.00 Jones Mitchell Lawrence
2023-10-05 Sale -1309.00 Finley John David
2023-09-29 Buy 15000.00 Finley John David
2023-09-29 Buy 20000.00 Williams Donald Allen
2023-09-15 Sale -300.00 Trenschel Robert J.
2023-09-14 Buy 15000.00 Finley John David

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Feb 13, 2024
4 Insider transactions 1 Feb 08, 2024
4 Insider transactions 1 Feb 08, 2024
4 Insider transactions 1 Feb 07, 2024
def Proxies and info statements 5 Feb 06, 2024
4 Insider transactions 1 Feb 01, 2024
4 Insider transactions 1 Feb 01, 2024
8-k 8K-related 19 Feb 01, 2024
8-k 8K-related 16 Jan 29, 2024
pre Proxies and info statements 3 Jan 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.